MRVI vs TXT · rev $117.3M vs P/E 19, rev $7.52B
Maravai Lifesciences Holdings Inc (MRVI) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
MRVI currently screens at market cap $1.93B. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the MRVI and TXT stock pages for the full models.
Not investment advice.